Skip to main content
MedPeer,Inc. logo

MedPeer,Inc. — Investor Relations & Filings

Ticker · 6095 ISIN · JP3921240002 LEI · 353800ORAK2PGV4HEZ88 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 65 across all filing types
Latest filing 2024-02-13 Interim / Quarterly Rep…
Country JP Japan
Listing T 6095

About MedPeer,Inc.

https://medpeer.co.jp/

MedPeer, Inc. is a healthcare technology company operating under the mission "Supporting Doctors, Helping Patients." The company's business is structured around two main pillars: the Doctor Platform and the Healthcare Institution Support Platform. The core Doctor Platform business centers on "MedPeer," a collective intelligence community for physicians to share clinical knowledge and insights. This segment also offers career support services for medical professionals. The Healthcare Institution Support Platform provides solutions aimed at enhancing the operational efficiency of medical facilities, including clinics and pharmacies. By leveraging the collective expertise of healthcare professionals, MedPeer aims to reinvent healthcare.

Recent filings

Filing Released Lang Actions
四半期報告書－第20期第1四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for MedPeer, Inc., covering the first quarter of the 20th fiscal year (October 1, 2023, to December 31, 2023). It contains detailed financial statements, including the balance sheet, income statement, and segment information, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-02-13 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the "当社第19回定時株主総会" (The 19th Annual General Meeting of Shareholders). Section 2 details the resolutions, which include dividend approval, articles of incorporation changes, and the election of directors. The presence of detailed voting results (votes for, against, abstentions) for resolutions passed at a General Meeting strongly indicates this document reports the outcome of that meeting. This aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2023-12-19 Japanese
内部統制報告書－第19期(2022/10/01－2023/09/30)
Governance Information Classification · 1% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly states its legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項). It details the scope, criteria, and procedures for evaluating internal controls over financial reporting as of the fiscal year-end (2023年９月30日) and concludes that the internal controls are effective. This document structure and content strongly align with the requirements for an Internal Control Report, which is typically filed alongside the Annual Report (10-K) in Japan, but based on the provided definitions, it most closely matches the scope of an Audit Report/Information (AR) or a specific regulatory filing. Given the specific nature of reporting on internal controls over financial reporting, and the lack of a direct 'Internal Control Report' code, it is a comprehensive report detailing internal control assessment, which is closer to an 'Audit Report / Information' (AR) than a simple earnings release or management discussion. However, in the context of US SEC filings where this classification system originates, the assessment of internal controls over financial reporting is a mandatory part of the 10-K. Since this is a standalone Japanese filing focused solely on internal controls assessment, and it is a comprehensive report (not an announcement of a report), 'AR' (Audit Report / Information) is the most appropriate fit among the given options for a detailed, non-annual financial statement report.
2023-12-19 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document text contains Japanese characters and includes the title "有価証券報告書（通常方式）" which translates to 'Securities Report (Normal Format)'. It explicitly mentions the submission date (2023年12月19日), the company name (メドピア株式会社 / MedPeer, Inc.), and confirms the appropriateness of the contents of the '第19期（自2022年10月１日 至2023年９月30日）の有価証券報告書' (19th fiscal period Securities Report for Oct 1, 2022, to Sep 30, 2023). A Securities Report in the context of Japanese regulation (equivalent to the US 10-K) is a comprehensive annual filing. Although the specific document provided seems to be a certification/confirmation document related to the filing ('確認書' - Confirmation document), the core subject matter is the Annual Securities Report. Given the options, the closest and most appropriate classification for the underlying document being certified is the Annual Report (10-K), as this confirmation relates directly to the annual filing's accuracy. The document length is very short (620 chars), suggesting it might be an accompanying certification rather than the full report, but since the content explicitly references the full annual report ('有価証券報告書') and its fiscal period, classifying it as 10-K is the most informative choice over a generic RPA or RNS, as it pertains to the annual filing itself. FY 2023
2023-12-19 Japanese
有価証券報告書－第19期(2022/10/01－2023/09/30)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial data, management indicators, and business information for the fiscal year ending September 30, 2023. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2023
2023-12-19 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の８第１項' (Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the quarterly report, rather than containing the financial statements themselves. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q3 2023
2023-08-09 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.